Who owns TRAVERE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Travere Therapeutics stock

Who bought or sold TRAVERE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Simplex Trading 203k $7.8M -2% Dec 2025
 View chart
Hrt Financial 121k $3.6M 100% Mar 2026
 View chart
IMC-Chicago 48k $1.4M -56% Mar 2026
 View chart
Group One Trading 40k $1.2M -67% Mar 2026
 View chart

Who sold out of Travere Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Jpmorgan Chase & Co Sep 2025 445k $11M
Exome Asset Management Sep 2025 110k $2.6M